Korean J Transplant.  2023 Jun;37(2):79-84. 10.4285/kjt.23.0015.

Optimal timing of heart transplantation in patients with an implantable left ventricular assist device

• Sohn SH
• Kang Y
• Hwang HY
• Chee HK

• KMID: 2544111
• DOI: http://doi.org/10.4285/kjt.23.0015

Abstract

Heart transplantation (HTPL) has been established as the gold-standard surgical treatment for end-stage heart failure. However, the use of a left ventricular assist device (LVAD) as a bridge to HTPL has been increasing due to the limited availability of HTPL donors. Currently, more than half of HTPL patients have a durable LVAD. Advances in LVAD technology have provided many benefits for patients on the waiting list for HTPL. Despite their advantages, LVADs also have limitations such as loss of pulsatility, thromboembolism, bleeding, and infection. In this narrative review, the benefits and shortcomings of LVADs as a bridge to HTPL are summarized, and the available literature evaluating the optimal timing of HTPL after LVAD implantation is reviewed. Because only a few studies have been published on this issue in the current era of third-generation LVADs, future studies are needed to draw a definite conclusion.

Keyword

Transplantation; Ventricular assist device; Outcomes

Reference

1. Park JJ, Lee CJ, Park SJ, Choi JO, Choi S, Park SM, et al. 2021; Heart failure statistics in Korea, 2020: a report from the Korean Society of Heart Failure. Int J Heart Fail. 3:224–36. DOI: 10.36628/ijhf.2021.0023. PMID: 36262554. PMCID: PMC9536683.

2. Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr, Hsich E, et al. 2019; The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 38:1056–66. DOI: 10.1016/j.healun.2019.08.004. PMID: 31548031. PMCID: PMC6816343.

3. Frazier OH, Rose EA, Macmanus Q, Burton NA, Lefrak EA, Poirier VL, et al. 1992; Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 53:1080–90. DOI: 10.1016/0003-4975(92)90393-I. PMID: 1596133.

4. Truby LK, Garan AR, Givens RC, Takeda K, Takayama H, Trinh PN, et al. 2018; Ventricular assist device utilization in heart transplant candidates: nationwide variability and impact on waitlist outcomes. Circ Heart Fail. 11:e004586. DOI: 10.1161/CIRCHEARTFAILURE.117.004586. PMID: 29666073. PMCID: PMC5912344.

5. Bowen RE, Graetz TJ, Emmert DA, Avidan MS. 2020; Statistics of heart failure and mechanical circulatory support in 2020. Ann Transl Med. 8:827. DOI: 10.21037/atm-20-1127. PMID: 32793672. PMCID: PMC7396255.

6. Grimm JC, Magruder JT, Crawford TC, Fraser CD 3rd, Plum WG, Sciortino CM, et al. 2016; Duration of left ventricular assist device support does not impact survival after US heart transplantation. Ann Thorac Surg. 102:1206–12. DOI: 10.1016/j.athoracsur.2016.04.022. PMID: 27319984.

7. John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, et al. 2010; Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg. 140:174–81. DOI: 10.1016/j.jtcvs.2010.03.037. PMID: 20447659.

8. Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, et al. 1995; Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 222:327–36. DOI: 10.1097/00000658-199509000-00010. PMID: 7677462. PMCID: PMC1234813.

9. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, et al. 2001; Left ventricular assist system. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 122:1186–95. DOI: 10.1067/mtc.2001.118274. PMID: 11726895.

10. Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. 2019; The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 38:114–26. DOI: 10.1016/j.healun.2018.11.013. PMID: 30691593.

11. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. 2017; Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 135:e146–603. DOI: 10.1161/CIR.0000000000000491.

12. Purohit SN, Cornwell WK 3rd, Pal JD, Lindenfeld J, Ambardekar AV. 2018; Living without a pulse: the vascular implications of continuous-flow left ventricular assist devices. Circ Heart Fail. 11:e004670. DOI: 10.1161/CIRCHEARTFAILURE.117.004670. PMID: 29903893. PMCID: PMC6007027.

13. Kranzl M, Stoiber M, Schaefer AK, Riebandt J, Wiedemann D, Marko C, et al. 2021; Driveline features as risk factor for infection in left ventricular assist devices: meta-analysis and experimental tests. Front Cardiovasc Med. 8:784208. DOI: 10.3389/fcvm.2021.784208. PMID: 34977190. PMCID: PMC8716483.

14. Kilic A, Conte JV, Baumgartner WA, Russell SD, Merlo CA, Shah AS. 2014; Does recipient age impact functional outcomes of orthotopic heart transplantation? Ann Thorac Surg. 97:1636–42. DOI: 10.1016/j.athoracsur.2013.12.048. PMID: 24656958.

15. Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K. 2013; Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 145:575–81. DOI: 10.1016/j.jtcvs.2012.09.095. PMID: 23321132.

16. Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, et al. 2015; Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support. J Heart Lung Transplant. 34:89–99. DOI: 10.1016/j.healun.2014.09.007. PMID: 25444372.

17. Fukuhara S, Takeda K, Polanco AR, Takayama H, Naka Y. 2016; Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: a new challenge. J Thorac Cardiovasc Surg. 151:872–80. DOI: 10.1016/j.jtcvs.2015.10.024. PMID: 26896362.

18. Brown CR, Khurshan F, Chen Z, Groeneveld PW, McCarthy F, Acker M, et al. 2019; Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: is timing of the essence? J Thorac Cardiovasc Surg. 157:2315–24. DOI: 10.1016/j.jtcvs.2018.12.118. PMID: 30955956.

19. Truby LK, Takeda K, Topkara VK, Takayama H, Garan AR, Yuzefpolskaya M, et al. 2018; Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 37:1433–42. DOI: 10.1016/j.healun.2018.07.013. PMID: 30206023.

20. Yu SH, Chou HW, Wang CH, Tsao CI, Fu HY, Chen KP, et al. 2022; Impact of duration of mechanical support on heart transplantation: hasty transplantation may not have a good long-term outcome. Clin Transplant. 36:e14746. DOI: 10.1111/ctr.14746.

21. Wieselthaler GM, Driscoll GO, Jansz P, Khaghani A, Strueber M. HVAD Clinical Investigators. 2010; Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant. 29:1218–25. DOI: 10.1016/j.healun.2010.05.016. PMID: 20646936.

22. Chatterjee A, Feldmann C, Hanke JS, Ricklefs M, Shrestha M, Dogan G, et al. 2018; The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD). J Thorac Dis. 10(Suppl 15):S1790–3. DOI: 10.21037/jtd.2017.10.124. PMID: 30034854. PMCID: PMC6035956.

23. Bourque K, Dague C, Farrar D, Harms K, Tamez D, Cohn W, et al. 2006; In vivo assessment of a rotary left ventricular assist device-induced artificial pulse in the proximal and distal aorta. Artif Organs. 30:638–42. DOI: 10.1111/j.1525-1594.2006.00276.x. PMID: 16911321.

24. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, et al. 2012; Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 125:3191–200. DOI: 10.1161/CIRCULATIONAHA.111.058412. PMID: 22619284.

25. Stehlik J, Kirklin JK. 2021; The long and winding road to an effective left ventricular assist device: the demise of Medtronic's HVAD. Circulation. 144:509–11. DOI: 10.1161/CIRCULATIONAHA.121.056027. PMID: 34106733.